MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4...
Leadership
Christopher A. Kroeger M.B.A., M.D., Ph.D.Founder
Founder, President, CEO & Director
Robert C. Malenka M.D., Ph.D.Founder
Co-Founder, Member of Scientific Advisory Board & Director
